Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804349 · ClinicalTrials.gov registry record · Phase 4
Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients
A Phase 4 study, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT00804349 is a Phase 4 study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 6 participants.
The verdict
NCT00804349, a Phase 4 study, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
Heart Failure affects 5-6 million Americans and there are about 550 thousand new cases of heart failure every year. There are approximately 3 million hospital admission for acute decompensated heart failure with hospital readmission rate of 20% at 30 days and 50% at 60 day, costing up to 20 billion dollars per year. In our previous study we have discovered that sleep disordered breathing is prevalent in 70% of patients with acute decompensated heart failure. We hypothesize that, detection and treatment of sleep disordered breathing in acute decompensated heart failure patients will reduce episodic hypoxic events during acute decompensation and may decrease hospital length of stay and reduce future readmissions.
Interventions
- DEVICE Autotitrating Positive Airway Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804349
The ClinicalTrials.gov registry entry for NCT00804349 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autotitrating Positive Airway Pressure is the first listed.
NCT00804349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00804349 about?
NCT00804349 is a clinical study titled "Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients". Heart Failure affects 5-6 million Americans and there are about 550 thousand new cases of heart failure every year. There are approximately 3 million hospital admission for acute decompensated heart failure with hospital readmission rate of 20% at 30 days and 50% at 60 day, costing up to 20 billion ...
What is the current status of trial NCT00804349?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2008-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00804349?
The interventions under investigation include: Autotitrating Positive Airway Pressure (DEVICE).
Who is sponsoring clinical trial NCT00804349?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.